Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 6, 2014
Combining gemcitabine, cisplatin, and ifosfamide (GIP) is active in patients with relapsed metastatic germ-cell tumors (GCT): a prospective multicenter GETUG phase II trialK Fizazi, G Gravis, A Flechon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 29, 2007
Assessing prognosis and optimizing treatment in patients with postchemotherapy viable nonseminomatous germ-cell tumors (NSGCT): results of the sCR2 international studyK Fizazi, J Oldenburg, A Dunant, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2015
Vinflunine-gemcitabine versus vinflunine-carboplatin as first-line chemotherapy in cisplatin-unfit patients with advanced urothelial carcinoma: results of an international randomized phase II trial (JASINT1)M De Santis, P J Wiechno, J Bellmunt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 24, 2017
A randomized, double-blind, placebo-controlled phase II study of maintenance therapy with tasquinimod in patients with metastatic castration-resistant prostate cancer responsive to or stabilized during first-line docetaxel chemotherapyK Fizazi, A Ulys, L Sengeløv, et al.
Frontiers in Oncology|February 6, 2023
Urachal carcinoma: a large retrospective multicentric study from the French Genito-Urinary Tumor GroupM Guerin, C Miran, E Colomba, et al.
Bone Marrow Transplantation|December 8, 2015
Prognostic impact of progression to induction chemotherapy and prior paclitaxel therapy in patients with germ cell tumors receiving salvage high-dose chemotherapy in the last 10 years: a study of the European Society for Blood and Marrow Transplantation Solid Tumors Working PartyA Necchi, R Miceli, M Bregni, et al.
ESMO Open|January 30, 2021
Immune checkpoint inhibitor treatment of a first cancer is associated with a decreased incidence of second primary cancerP Heudel, S Chabaud, D Perol, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 16, 2012
Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancerJ Beyer, P Albers, R Altena, et al.
Pageof 2